A small number of users may experience gastrointestinal effects so severe that they need to stop taking the medication
You can also have a fibre supplement
What happens if the clinician determines I am not a candidate
Week 5-8: Dose Increase The dose is increased to 0.5 mg weekly
De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrm E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis
Most patients begin to see weight loss within the first 48 weeks